Clinical trial

RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

NCT00193856

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-10-01

PhasePHASE3

Study timeline

Study start (unknown)2003-10-01Date precision: month

Registry last updated2017-10-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Leuprorelin AcetateDRUG

Zoledronic AcidDRUG · verified · RxNorm: zoledronic acid

Conventional external beam therapyRADIATION

Sponsors & collaborators

Trans Tasman Radiation Oncology Grouplead sponsor

National Health and Medical Research Council, Australiacollaborator

Hunter Medical Research Institute (HMRI)collaborator

Health Research Council, New Zealandcollaborator

Novartis Pharmaceuticalscollaborator

Cancer Society of New Zealandcollaborator

University of Newcastle, Australiacollaborator

Calvary Mater Newcastle, Australiacollaborator

Maitland Cancer Appealcollaborator

Abbottcollaborator

Mapped research locations

SydneyNew South Wales, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00193856 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.